MULTICELL TECHNOLOGIES, INC.

(MCET)
Delayed Other OTC  -  03:47 2021-04-01 pm EDT
0.001100 USD   -.--%
2015MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt
CI
2014MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application
CI
2014MultiCell Technologies Inc. Files U.S. and International Patent Applications for the Treatment of Liver Cancer
CI
 SummaryChartsNewsCompany 
Company
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company. The Company and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications. The Company's portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical... 
More about the company
All news about MULTICELL TECHNOLOGIES, INC.
2015MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt
CI
2014MultiCell Technologies Files Novel Antibody-Drug Conjugate Patent Application
CI
2014MultiCell Technologies Inc. Files U.S. and International Patent Applications for the Tr..
CI
2014MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt
CI
2014MultiCell Technologies, Inc. Files U.S. Provisional Patent Application for its New Clas..
CI
2013MULTICELL TECHNOLOGIES, INC. : MultiCell Technologies Files U.S. Patent Application for Ta..
PR
2013MultiCell Technologies, Inc. Files U.S. Patent Application for Targeted Delivery of MCT..
CI
2013MULTICELL TECHNOLOGIES, INC. : MultiCell Technologies Expands Scope of Research Agreement ..
PR
2013MultiCell Technologies, Inc. and Genisphere, LLC Evaluate Targeted Delivery of MCT-485
CI
2013Multicell Technologies, Inc. Reports Earnings Results for the Second Quarter and Six Mo..
CI
2013MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt
CI
2012Grant G. Miller Joins Board of MultiCell Technologies, Inc
CI
2012MultiCell Technologies, Inc. Adds Scott Lukeman to its Board of Directors
CI
2012MultiCell Technologies, Inc. Updates Preclinical Results for MCT-465 and MCT-485 in Pri..
CI
2012MultiCell Technologies, Inc. Auditor Raises 'Going Concern' Doubt
CI
More news
News in other languages on MULTICELL TECHNOLOGIES, INC.

- No features available -

More news
Chart MULTICELL TECHNOLOGIES, INC.
Duration : Period :
MultiCell Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
MULTICELL TECHNOLOGIES, INC.266.67%0
MODERNA, INC.-26.44%73 092
IQVIA HOLDINGS INC.-16.80%43 781
LONZA GROUP AG-26.44%43 083
SEAGEN INC.13.72%32 426
ALNYLAM PHARMACEUTICALS, INC.28.89%26 235